10 results
dm2 management medications comparison oral table classification diagnosis differential disorders dmii dosing dpp4 fda hypoglycemics indications inpatient ketones ketosis mellitus
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... SGLT2 inhibitors ... adverse CV events, Improved ... comparison #management #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... #Inhibitors #Pharmacology ... #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP-4 inhibitor ... receptor agonist, SGLT2i ... α-glucosidase inhibitor ... #Medications #pharmacology ... comparison #table #endocrinology
Effects on body weight of various classes of type-2 diabetes medications. - Metformin - Weight Loss
classes of type-2 diabetes ... Weight Loss + - SGLT ... -2 inhibitors - ... Weight Gain ++ - Insulin ... weightgain #comparison #pharmacology
Oral Hypoglycemics in Diabetes Management 1 INSULIN SENSITIZER • TZD -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Glucophage) 2 INSULIN ... Prandase) • SGLT ... #Management #pharmacology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... • Euglycemic diabetic ... #Inhibitors #Pharmacology ... #endocrinology
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Norepinephrine Reuptake Inhibitors ... Cymbalta) - GAD, MDD, Diabetic ... Serotonin-Norepinephrine Reuptake Inhibitors ... #Indications #Pharmacology ... #Psychiatry #FDA
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
-> Stimulates Insulin ... will stimulate insulin ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Ketosis Disorders Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
produce endogenous insulin ... • Diabetic ketoacidosis ... variant seen with SGLT ... inhibitors & pregnancy ... diagnosis #management #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
Rybelsus was finally approved ... when compared to SGLT2 ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology
No results found for "ASPD psychiatry pharmacology diabetes insulin endocrinology inhibitors approved sglt2"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ASPD #psychiatry #pharmacology #diabetes #insulin #endocrinology #inhibitors #approved #sglt2